Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan.
Bioconjug Chem. 2020 Mar 18;31(3):547-553. doi: 10.1021/acs.bioconjchem.0c00064. Epub 2020 Feb 7.
Delivery of biomacromolecules via endocytic pathways requires the efficient accumulation of cargo molecules into endosomes, followed by their release to the cytosol. We propose a unique intracellular delivery strategy for bioactive molecules using a new potent macropinocytosis-inducing peptide derived from stromal-derived factor 1α (SN21). This peptide allowed extracellular materials to enter cells through the activation of macropinocytosis. To provide the ability to release internalized cargoes from endosomes, we conjugated SN21 with membrane-lytic peptides. The combination of a macropinocytosis-inducing peptide and a membrane-lytic peptide successfully delivered functional siRNA and proteins, which include antibodies, Cre recombinase, and an artificial transcription regulator protein having a transcription activator-like effector (TALE) motif. This study shows the feasibility of combining the physiological stimulation of macropinocytosis with the physicochemical disruption of endosomes as a strategy for intracellular delivery.
生物大分子通过内吞途径的传递需要将货物分子有效地积累到内体中,然后将其释放到细胞质中。我们提出了一种使用源自基质衍生因子 1α(SN21)的新型强效巨胞饮诱导肽的独特的生物活性分子的细胞内传递策略。该肽允许通过巨胞饮作用将细胞外物质进入细胞。为了提供从内体中释放内化货物的能力,我们将 SN21 与膜裂解肽缀合。巨胞饮诱导肽和膜裂解肽的组合成功地传递了功能性 siRNA 和蛋白质,包括抗体、Cre 重组酶和具有转录激活子样效应物(TALE)基序的人工转录调节蛋白。这项研究表明,将巨胞饮的生理刺激与内体的物理化学破坏相结合作为细胞内传递策略是可行的。